Dow Down0.71% Nasdaq Down0.04%

Myriad Genetics, Inc. (MYGN)

-NasdaqGS
33.87 Down 0.22(0.65%) 2:04PM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.5
Mean Recommendation (last week):2.5
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:39.08
Median Target:39.50
High Target:50.00
Low Target:25.00
No. of Brokers:12

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jan 7, 2016Deutsche BankInitiated Buy
Aug 25, 2015Wells FargoUpgradeMarket PerformOutperform
Jul 21, 2015Gabelli & CoInitiated Buy
Mar 10, 2015UBSInitiated Sell
Feb 4, 2015MizuhoDowngradeBuyNeutral
Jan 7, 2015BarclaysInitiated Overweight
Apr 4, 2014MizuhoUpgradeNeutralBuy
Feb 5, 2014Ladenburg ThalmannDowngradeBuyNeutral
Dec 30, 2013MizuhoDowngradeBuyNeutral
Oct 1, 2013Ladenburg ThalmannUpgradeNeutralBuy

More Upgrades & Downgrades for MYGN

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4444
Buy4455
Hold7777
Underperform3333
Sell0000

Data provided by Thomson/First Call


Currency in USD.